# Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

> **NCT03398668** · NA · COMPLETED · sponsor: **Neurolief Ltd.** · enrollment: 55 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Relievion device- Treatment stimulation
- **DEVICE:** Relievion Device- Sham stimulation

## Key facts

- **NCT ID:** NCT03398668
- **Lead sponsor:** Neurolief Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398668, "Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03398668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*